 Boston Scientific Corp. shares BSX, -4.46 rose 3.3 premarket Wednesday, after the medical device maker reported lower earnings for the first quarter than a year ago but still beat consensus estimates. The company posted net income of 97 million, or 7 cents a share, for the quarter, down from 327 million, or 23 cents a share, in the year-earlier period. 